Exscientia · pitchdeck
Exscientia | Investor Presentation Deck | 93 slides
93 pages · 4 arc beats · 2 loops
Exscientia | Investor Presentation Deck | 93 slides
Exscientia · 2024-03 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707580859093
Deck intelligence map
4 coverage by narrative range · generated from this deck JSON
Narrative range 61 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
What Is 5 slides 100% 5/5 slides 100% 5/5 slides · 23 hits — 0/5 slides
20% 1/5 slides 20% 1/5 slides 100% 5/5 slides — 0/5 slides
Problem (Identify pain) 3 slides 100% 3/3 slides 100% 3/3 slides · 16 hits — 0/3 slides
66.7% 2/3 slides 66.7% 2/3 slides 100% 3/3 slides 100% 3/3 slides Solution (Provide relief) 16 slides 100% 16/16 slides 100% 16/16 slides · 83 hits — 0/16 slides
93.8% 15/16 slides · 17 hits 62.5% 10/16 slides 100% 16/16 slides · 17 hits — 0/16 slides
Traction 37 slides 100% 37/37 slides 100% 37/37 slides · 214 hits — 0/37 slides
21.6% 8/37 slides 45.9% 17/37 slides 100% 37/37 slides · 38 hits — 0/37 slides
Slide inventory
93 every slide · same image gating as the playbook
01
The slide uses a high-contrast black background with orange accents, typical of biotech branding.front_matter
Open slide detailBeat · What Is
03
The slide uses a split-screen layout to contrast internal R&D with external partnerships, unified by a central 'Multiple Discovery Programmes' icon stack.present_solution
Open slide detailBeat · What Is
05
Uses a comparison framework to highlight value proposition.present_solution
Open slide detailBeat · What Is
08
The slide uses a hub-and-spoke diagram centered on a human silhouette to represent the integration of clinical design, data generation, target identification, Apresent_solution
Open slide detailLoop · Golden Circle
10
The slide uses a Gantt-style visualization for drug development stages.plan_implementation
Open slide detailLoop · Golden Circle
11
The slide uses a table structure to compare three partners (BMS, Merck KGaA, Sanofi) across four metrics: number of collaborations, cash inflows, milestones, anshow_traction
Open slide detailLoop · Golden Circle
12
Includes footnotes regarding tax withholding, cash composition, and share count.analyze_data
Open slide detailLoop · Golden Circle
14
The slide uses a circular, iterative process flow to represent the R&D pipeline.present_solution
Open slide detailLoop · Golden Circle
15
The slide uses a process-oriented timeline to show technological progression from simple GPCRs to complex novel targets.plan_implementation
16
The slide uses a timeline framework to map partnership complexity against platform value.show_traction
18
The slide uses a central vertical process flow with branching inputs and outputs.present_solution
19
The slide uses a timeline-like axis to represent 'Rank' and shows the shift in target positioning based on prompt precision.present_solution
20
The slide uses a numbered process flow mapped to a screenshot of a research interface.present_solution
22
Uses information theory to illustrate exponential search space reduction.argue_timing
23
Uses a flywheel-like diagram to represent iterative learning cycles over time.frame_problem
24
The scatter plot demonstrates the 'active learning' selection process vs standard coverage properties.present_solution
25
The slide uses a horizontal layout to showcase four distinct technical pillars of the company's R&D infrastructure.other
Open slide detailBeat · Solution (Provide relief)
26
The slide uses a process flow diagram showing the transition from Target Product Profile (table) to MPO (code snippet) to Merit (scatter plot).present_solution
Open slide detailBeat · Solution (Provide relief)
27
The diagram illustrates a multi-modal AI pipeline for drug discovery, emphasizing flexibility in data inputs and model architectures.present_solution
Open slide detailBeat · Solution (Provide relief)
28
The slide features a 3D molecular model and a dashboard of experimental metrics (Potency, Selectivity, CNS Barrier, Solubility, Cellular Potency, Stability, Perpresent_solution
Open slide detailBeat · Solution (Provide relief)
29
MD stands for Molecular Dynamics. The slide features a 3D protein-ligand binding visualization.present_solution
Open slide detailBeat · Solution (Provide relief)
30
The slide uses a pyramid framework to show the progression of data and process maturity.present_solution
Open slide detailBeat · Solution (Provide relief)
32
The diagram is a classic flywheel or continuous improvement loop.present_solution
Open slide detailBeat · Solution (Provide relief)
33
Includes a process flow diagram for Chemical Synthesis, Compound Management, and Biological Testing.present_solution
Open slide detailBeat · Solution (Provide relief)
34
The slide uses a flywheel-style circular process diagram to show the integration of digital design and physical lab automation.present_solution
Open slide detailBeat · Solution (Provide relief)
35
The slide uses an isometric technical illustration to depict a modular lab setup.present_solution
Open slide detailBeat · Solution (Provide relief)
36
Uses a contrast-pairs framework to highlight the shift from common/similar processes to unique/varied processes.present_framework
Open slide detailBeat · Solution (Provide relief)
37
The slide uses a process flow diagram to map specific robotic solutions to different stages of laboratory automation.present_solution
Open slide detailBeat · Solution (Provide relief)
39
The slide uses a circular process flow to represent a proprietary R&D pipeline.present_solution
Open slide detailBeat · Solution (Provide relief)
40
The slide uses a process flow to demonstrate the efficacy of the platform in a specific patient case.show_traction
Open slide detailBeat · Solution (Provide relief)
41
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.show_traction
Open slide detailBeat · Traction
42
The slide uses a converging timeline/process flow to show how different patient types (Ovarian cancer vs AML) feed into a unified precision medicine testing plaplan_implementation
Open slide detailBeat · Traction
43
Uses a complex heatmap/dot-plot visualization to show drug sensitivity across different samples and cell lines.frame_problem
Open slide detailBeat · Traction
44
The slide uses a small multiples approach to show individual patient responses, then aggregates them into two groups (I and II) to demonstrate differential sensanalyze_data
Open slide detailBeat · Traction
47
The slide uses a molecular visualization as a background element to represent the drug target.show_traction
Open slide detailBeat · Traction
48
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).plan_implementation
Open slide detailBeat · Traction
49
The slide uses a human anatomy diagram to map specific cancer types to their locations, providing a visual representation of the addressable market.size_opportunity
Open slide detailBeat · Traction
50
Includes a biological pathway diagram and a list of potential cancer indications.size_opportunity
Open slide detailBeat · Traction
51
The slide uses a three-column layout to define the target product profile (TPP) for a CDK7 inhibitor.present_solution
Open slide detailBeat · Traction
52
The slide uses a color-coded heatmap to visualize performance against criteria.compare_peers
Open slide detailBeat · Traction
54
The slide uses two distinct charts to correlate drug exposure time with physiological toxicity (body weight change).analyze_data
Open slide detailBeat · Traction
55
The chart displays sensitivity across 60+ samples. The right side shows a volcano plot for pathway analysis and a conceptual diagram for combination testing.show_traction
Open slide detailBeat · Traction
56
The slide uses a waterfall plot for single-agent sensitivity and a heatmap for combination synergy, highlighting specific patient response rates for different mpresent_solution
Open slide detailBeat · Traction
57
Includes a Venn diagram and two line charts showing Log2FoldChange vs concentration.analyze_data
Open slide detailBeat · Traction
58
The slide features a 3D molecular visualization of the protein target.show_traction
Open slide detailBeat · Traction
59
The chart compares % Reduction PLN Weight across different doses of EXS4318 versus a failed competitor drug.show_traction
Open slide detailBeat · Traction
60
The slide uses a traffic-light color coding system to highlight the superior profile of EXS4318.compare_peers
Open slide detailBeat · Traction
61
The slide uses a process-flow layout with icons representing each stage.present_solution
Open slide detailBeat · Traction
62
The background features a 3D molecular visualization, likely representing the LSD1 protein target.plan_implementation
Open slide detailBeat · Traction
63
The slide uses a human anatomy diagram to map specific patient counts to disease locations.size_opportunity
Open slide detailBeat · Traction
64
The slide uses a hub-and-spoke diagram to illustrate the interaction of LSD1 with various protein complexes, receptors, and RNAs.establish_context
Open slide detailBeat · Traction
65
The slide uses a biological process diagram to explain the mechanism of action for a drug candidate ('539).present_solution
Open slide detailBeat · Traction
66
The slide uses a process flow diagram to explain the therapeutic mechanism.present_solution
Open slide detailBeat · Traction
68
The slide uses a three-column layout to define the technical requirements for a drug candidate.present_solution
Open slide detailBeat · Traction
69
The table uses a traffic-light color coding system to indicate performance against criteria.compare_peers
Open slide detailBeat · Traction
70
The slide outlines a specific workflow involving generative design, ML, and active learning.present_solution
Open slide detailBeat · Traction
71
The chart uses a scatter plot to visualize the Pareto front in drug discovery, highlighting the selection of compounds 1 and 2.present_solution
Open slide detailBeat · Traction
72
The slide uses two distinct chart types (dot plot and line chart with error bars) to illustrate the safety profile of the drug candidate '539.present_solution
Open slide detailBeat · Traction
73
Data shows heterogeneity of response across different patient samples, categorized by differentiation level.show_traction
Open slide detailBeat · Traction
74
The slide uses a heatmap to visualize synergy (green = yes, light green = no) across 6 drug combinations and 14 patient samples.present_solution
Open slide detailBeat · Traction
75
Includes statistical significance markers (asterisks) and safety observation regarding body weight.show_traction
Open slide detailBeat · Traction
76
Uses Bliss Independence Model for synergy calculation. Includes a heatmap of synergy across subtypes and dose-response curves for two specific models (DMS79 andpresent_solution
Open slide detailBeat · Traction
77
The heatmap displays AUC values for 16 patient samples across three treatments.frame_problem
78
The slide uses a two-column layout to contrast PK and Toxicology findings.present_solution
80
The background features a stylized molecular structure, emphasizing the biotech/pharma context.plan_implementation
81
The slide uses a three-column layout to summarize the value proposition of a drug candidate.present_solution
82
The slide uses a biological pathway diagram to illustrate the mechanism of action.present_solution
84
The slide uses a biological mechanism argument to establish a safety/efficacy advantage for the drug candidate '565.present_solution
85
The slide uses a heatmap-style table to visualize performance against criteria, with a specific focus on UGT1A1 inhibition risk.compare_peers
86
The slide uses a linear process flow to explain a complex drug discovery workflow.present_solution
87
The slide highlights the application of computational chemistry (molecular dynamics) to drug discovery, specifically focusing on binding site analysis.present_solution
88
The slide presents preclinical efficacy data for a MALT1 inhibitor ('565) in combination with Ibrutinib.show_traction
90
The table uses a heatmap-style color coding (red/green) to indicate risk levels.compare_peers